Cullinan Therapeutics, Inc.
CGEM
$8.95
$0.2052.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.83% | -14.58% | 23.94% | 34.71% | 10.83% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.72% | -29.66% | 35.78% | 137.75% | 52.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -28.71% | -13.65% | 24.19% | 36.04% | 11.70% |
|
|
|||||
| Total Current Assets | -28.71% | -13.65% | 24.19% | 36.04% | 11.70% |
| Net Property, Plant & Equipment | -33.61% | -33.47% | -30.37% | -36.53% | -35.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.43% | -20.26% | 0.22% | 0.22% | 0.22% |
| Total Assets | 28.98% | 28.43% | 32.05% | 30.51% | -12.73% |
|
|
|||||
| Total Accounts Payable | -8.25% | -32.53% | 122.40% | -37.63% | 82.52% |
| Total Accrued Expenses | 28.86% | 12.61% | 9.61% | 46.53% | 34.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.35% | -9.58% | -18.68% | -26.45% | -14.48% |
| Total Finance Division Other Current Liabilities | 84.00% | 57.22% | 8.30% | 115.53% | -83.70% |
| Total Other Current Liabilities | 84.00% | 57.22% | 8.30% | 115.53% | -83.70% |
| Total Current Liabilities | 24.74% | 8.92% | 3.24% | 19.31% | -16.22% |
|
|
|||||
| Total Current Liabilities | 24.74% | 8.92% | 3.24% | 19.31% | -16.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -73.21% | -60.51% | -51.43% | -44.44% | -41.96% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.16% | 3.99% | -1.92% | 11.54% | -19.00% |
|
|
|||||
| Common Stock & APIC | 45.79% | 46.44% | 46.46% | 46.58% | 12.06% |
| Retained Earnings | -75.10% | -83.33% | -81.07% | -103.11% | -125.26% |
| Treasury Stock & Other | 252.57% | -3.10% | 192.29% | 70.71% | 73.35% |
| Total Common Equity | 29.64% | 30.11% | 33.92% | 31.36% | -12.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.64% | 30.11% | 33.92% | 31.36% | -12.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.64% | 30.06% | 33.92% | 31.36% | -12.35% |
|
|
|||||